From post

Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts

, , , , , , и . Blood, 86 (10): 3970–3978 (1995)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts, , , , , , и . Blood, 86 (10): 3970–3978 (1995)Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL), , , , , , , , , и 5 other автор(ы). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 19 (3): 545–552 (2008)Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF, , , , , , , , , и 3 other автор(ы). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 12 (4): 471–477 (2001)CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group, , , , , , , , , и . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 23 (5): 1267–1273 (2012)Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group, , , , , , , , , и . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 (3): 580–586 (1994)Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia, , , , , , , , , и 4 other автор(ы). Journal of immunology (Baltimore, Md. : 1950), 180 (9): 6374–6384 (2008)Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL, , , , , , , , , и 3 other автор(ы). Blood, 104 (3): 634–641 (2004)Extremal distributions for the prophet region in the independent case., и . Ann. Oper. Res., 32 (1): 115-126 (1991)Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60), , , , , , , , , и 16 other автор(ы). The Lancet Oncology, 9 (2): 105–116 (2008)Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma, , , , , , , , , и . Blood, 107 (8): 3058–3064 (2006)